Core Therapeutic Areas

While we continue to pursue and invest in additional therapies in early and late stages of clinical development (see Worldwide Research & Development (WRD) and Biopharmaceuticals pages), the following are Pfizer's priority R&D therapeutic areas:

NOTE: For opportunities that fall into the pre-clinical proof of concept space, generally before phase 2b of development, visit the WRD links below. For post-clinical proof of concept, generally post phase 2a of development, visit the biopharmaceutical business units.

Cardiovascular and Metabolic Disease

• WRD
• Primary Care BU
• Specialty Care BU

Immunology

• WRD
• Primary Care BU
• Specialty Care BU

Inflammation

• WRD
• Primary Care BU
• Specialty Care BU

Neuroscience

• WRD
• Primary Care BU
• Specialty Care BU

Oncology

• WRD
• Oncology BU

Vaccines

• WRD
• Oncology BU
• Specialty Care BU

Pain and Sensory

• WRD
• Primary Care BU